Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 7/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 4/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5586137 | 0.83 | BRD4 (0.37) | BRD4MIFHDAC6CYP1A2CYP2C9 | |
| SCHEMBL5586347 | 0.83 | MIF (0.41) | MIFCYP1A2CYP2D6ALDH1A1GAA | |
| SCHEMBL9099352 | 0.80 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13170630 | 0.79 | POLB (0.35) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL18609127 | 0.79 | EPHX2 (0.46) | ALDH1A1GAAMAPTTSHR | |
| SCHEMBL9389664 | 0.78 | — | — | |
| SCHEMBL28312580 | 0.78 | CYP1A2 (0.43) | MIFHDAC6CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL28107913 | 0.77 | MTNR1A (0.35) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL15799592 | 0.77 | ITGB3 (0.41) | MIFCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL28329582 | 0.76 | TDP1 (0.32) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113286844-B | Method for producing non-isocyanate polyurethanes | 汉高股份有限及两合公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-113286844-A | Process for preparing non-isocyanate polyurethane | 汉高股份有限及两合公司 | 2021-08-20 | — | — | CN | disclosed |
| CN-111540949-A | Electrolyte for low-temperature operation of lithium titanate electrode, graphite electrode and lithium ion battery | 帅福得美国有限公司 | 2020-08-14 | — | — | CN | disclosed |
| US-20140378648-A1 | METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE BETA-HYDROXY-URETHANE UNIT AND/OR AT LEAST ONE UPSILON-HYDROXY-URETHANE UNIT | SOULES AURÉLIEN (FR) | 2014-12-25 | — | — | US | disclosed |
| EP-1173899-A4 | NEW ELECTROLYTES AND LITHIUM ION BATTERY USING THE SAME | LG CHEMICAL LTD (KR) | 2007-01-17 | — | — | EP | disclosed |
| US-6692874-B2 | STABILITY OF CHARGING, DISCHARGING CYCLES AT LOW TEMPERATURE; ALKYL CARBONATE SOLVENT | LG CHEMICAL CO., LTD. (KR) | 2004-02-17 | — | — | US | disclosed |
| US-20030087162-A1 | Stability of charging, discharging cycles at low temperature; alkyl carbonate solvent | LG ENERGY SOLUTION, LTD. (KR) | 2003-05-08 | — | — | US | disclosed |
| EP-1173899-A1 | NEW ELECTROLYTES AND LITHIUM ION BATTERY USING THE SAME | LG Chemical Co. Ltd (KR) | 2002-01-23 | — | — | EP | disclosed |
| WO-2001052340-A1 | NEW ELECTROLYTES AND LITHIUM ION BATTERY USING THE SAME | LG CHEMICAL CO., LTD (KR) | 2001-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378648-A1 | METHOD FOR PREPARING A COMPOUND COMPRISING AT LEAST ONE BETA-HYDROXY-URETHANE UNIT AND/OR AT LEAST ONE UPSILON-HYDROXY-URETHANE UNIT | OTUB1, UCHL1, UBE2E1 | BRD4 2488/4885MIF 4069/4885HDAC6 3026/4885 |
| US-20030087162-A1 | Stability of charging, discharging cycles at low temperature; alkyl carbonate solvent | SCO2, KCNN1, KCNN2 | BRD4 1659/4885MIF 3810/4885HDAC6 3471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.